{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:14:03Z","timestamp":1789748043468,"version":"4.0.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>There is uncertainty in the treatment options for resectable hypopharyngeal squamous cell carcinoma.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A systematic review of randomised controlled trials (RCTs) was performed. Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library), MEDLINE, EMBASE, Science Citation Index, and Conference Proceedings databases and trial registries were searched until November 2020 for randomized controlled trials performed on resectable hypopharyngeal squamous cell carcinoma. Two systematic review authors independently identified studies and extracted data. The primary outcomes evaluated were overall survival, disease-free survival, any recurrence, local recurrence, loco-regional recurrence, distal recurrence and laryngectomy-free survival. The secondary outcomes were response rates following neoadjuvant treatment and comparison of treatment-related toxicity. Assessment of risk of bias was performed for the selected studies using Cochrane\u2019s tool for assessing risk of bias. The studies were evaluated for the quality of evidence using GRADE (Grading of Recommendations, Assessment, Development and Evaluations). Risk ratios (RR), rate ratios, and hazard ratios (HR) were calculated along with 95% confidence intervals (95% CI). The Meta-analysis was performed using a random-effects model.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Five RCTs met the inclusion criteria for this review. The risk of bias was unclear or high for the trials. Non-organ preservation(n = 140) versus organ preservation (n = 144) (two trials): no statistically significant difference could be identified for any of the primary outcomes. Concurrent chemoradiotherapy (n = 37) versus sequential chemotherapy followed by radiotherapy (n = 34) (one trial): no statistically significant difference was noted between the two treatment arms for overall survival, disease-free survival and loco-regional recurrence. Laryngectomy-free survival was found to be superior in concurrent chemoradiotherapy arm (HR:0.28, 95% CI 0.13, 0.57). Induction chemotherapy followed by concurrent chemoradiotherapy (n = 53) versus induction chemotherapy followed by radiotherapy (n = 60) (one trial): no statistically significant difference was noted between the treatment arms for overall survival, disease-free survival and laryngectomy-free survival. Preoperative radiotherapy (n = 24) versus postoperative radiotherapy (n = 23) (one trial): overall survival was found to be better in the postoperative radiotherapy arm (HR:2.44, 95% CI1.18, 5.03). No statistically significant difference was noted in terms of treatment-related toxicity.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>There are considerable uncertainties in the management of resectable hypopharyngeal cancer.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Trail registration<\/jats:title>\n<jats:p>PROSPERO registration: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42019155613\" xlink:type=\"simple\">CRD42019155613<\/jats:ext-link>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0277460","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T19:03:25Z","timestamp":1669748605000},"page":"e0277460","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Treatment options for resectable hypopharyngeal squamous cell carcinoma: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1371","volume":"17","author":[{"given":"Smriti","family":"Panda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirabu","family":"Sakthivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0313-9134","authenticated-orcid":true,"given":"Kurinchi S.","family":"Gurusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Thakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"pone.0277460.ref001","unstructured":"5-Hypopharynx-fact-sheet.pdf [Internet]. [cited 2021 Mar 15]. Available from: https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/5-Hypopharynx-fact-sheet.pdf"},{"key":"pone.0277460.ref002","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12885-019-5412-z","article-title":"Comparative efficacy of six therapies for Hypopharyngeal and laryngeal neoplasms: a network meta-analysis","volume":"19","author":"J Che","year":"2019","journal-title":"BMC Cancer"},{"key":"pone.0277460.ref003","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0889-8588(05)70210-0","article-title":"Organ preservation for carcinoma of the larynx and hypopharynx.","volume":"15","author":"AS Garden","year":"2001","journal-title":"Hematol Oncol Clin North Am"},{"key":"pone.0277460.ref004","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1245\/s10434-017-5770-1","article-title":"Lymph Node Ratio Predicts Recurrence and Survival for Patients with Resectable Stage 4 Hypopharyngeal Cancer","volume":"24","author":"WC Lo","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"pone.0277460.ref005","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1017\/S0022215100144159","article-title":"Laryngeal preservation by treatment with induction chemotherapy and radiotherapy protocol for stage III & IV carcinoma larynx\u2014results of a pilot study.","volume":"113","author":"A Thakar","year":"1999","journal-title":"J Laryngol Otol"},{"key":"pone.0277460.ref006","first-page":"299","article-title":"Surgical treatment of hypopharyngeal cancer: a review of the literature and proposal for a decisional flow-chart","volume":"33","author":"F Mura","year":"2013","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"pone.0277460.ref007","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer","volume":"324","author":"Department of Veterans Affairs Laryngeal Cancer Study Group","year":"1991","journal-title":"N Engl J Med"},{"key":"pone.0277460.ref008","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer","volume":"349","author":"AA Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"pone.0277460.ref009","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/88.13.890","article-title":"Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group","volume":"88","author":"JL Lefebvre","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"pone.0277460.ref010","unstructured":"National Comprehensive Cancer Network. Head and Neck Cancer (Version 1.2021). https:\/\/www.nccn.org\/login?ReturnURL=https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf. Accessed August 10, 2021."},{"key":"pone.0277460.ref011","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.oraloncology.2018.09.025","article-title":"Hypopharyngeal cancer: A state of the art review","volume":"86","author":"JC Garneau","year":"2018","journal-title":"Oral Oncol"},{"key":"pone.0277460.ref012","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/2278-330X.136764","article-title":"Organ preservation strategies: Review of literature and their applicability in developing nations","volume":"3","author":"M Dandekar","year":"2014","journal-title":"South Asian J Cancer"},{"key":"pone.0277460.ref013","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/S0022215118000555","article-title":"Management of advanced hypopharyngeal carcinoma: systematic review of survival following surgical and non-surgical treatments.","volume":"132","author":"A. Habib","year":"2018","journal-title":"J Laryngol Otol"},{"key":"pone.0277460.ref014","first-page":"CRD42019155613","article-title":"Interventions for managing hypopharyngeal cancer: a systematic review and network meta-analysis.","author":"A Thakar","year":"2019","journal-title":"PROSPERO"},{"key":"pone.0277460.ref015","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"A Liberati","year":"2009","journal-title":"BMJ"},{"key":"pone.0277460.ref016","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"JPT Higgins","year":"2011","journal-title":"BMJ"},{"key":"pone.0277460.ref017","unstructured":"RevMan 5 download [Internet]. [cited 2021 Mar 16]. Available from: \/online-learning\/core-software-cochrane-reviews\/revman\/revman-5-download"},{"key":"pone.0277460.ref018","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.","volume":"17","author":"MK Parmar","year":"1998","journal-title":"Stat Med"},{"key":"pone.0277460.ref019","unstructured":"What is GRADE? | BMJ Best Practice [Internet]. [cited 2021 Mar 16]. Available from: https:\/\/bestpractice.bmj.com\/info\/toolkit\/learn-ebm\/what-is-grade\/"},{"key":"pone.0277460.ref020","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00005537-199705000-00017","article-title":"Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas","volume":"107","author":"C Beauvillain","year":"1997","journal-title":"The Laryngoscope"},{"key":"pone.0277460.ref021","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1093\/annonc\/mds065","article-title":"Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891.","volume":"23","author":"JL Lefebvre","year":"2012","journal-title":"Ann Oncol."},{"key":"pone.0277460.ref022","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/00016480902914080","article-title":"Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma.","volume":"130","author":"JM Prades","year":"2010","journal-title":"Acta Otolaryngol"},{"key":"pone.0277460.ref023","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/1097-0142(197704)39:4<1445::AID-CNCR2820390415>3.0.CO;2-6","article-title":"Results of a randomized clinical trial of preoperative irradiation versus postoperative in treatment of tumors of the hypopharynx","volume":"39","author":"C Vandenbrouck","year":"1977","journal-title":"Cancer"},{"key":"pone.0277460.ref024","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.ijrobp.2020.07.2292","article-title":"Adding Induction Chemotherapy to Preoperative Concurrent Chemoradiotherapy Does Not Improve the Treatment Results in Locally Advanced Hypopharyngeal Carcinoma: A Randomized Phase II Trial","volume":"108","author":"J Yi","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"pone.0277460.ref025","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jnci\/djp007","article-title":"Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation","volume":"101","author":"Y Pointreau","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"pone.0277460.ref026","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"JB Vermorken","year":"2007","journal-title":"N Engl J Med"},{"key":"pone.0277460.ref027","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.","volume":"12","author":"CM Nutting","year":"2011","journal-title":"Lancet Oncol."},{"key":"pone.0277460.ref028","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2013.54.6309","article-title":"Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer","volume":"32","author":"EEW Cohen","year":"2014","journal-title":"J Clin Oncol"},{"key":"pone.0277460.ref029","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(13)70011-1","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.","volume":"14","author":"O Haddad R","year":"2013","journal-title":"Lancet Oncol."},{"key":"pone.0277460.ref030","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"L Wood","year":"2008","journal-title":"BMJ"},{"key":"pone.0277460.ref031","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2011.05.036","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site.","volume":"100","author":"P Blanchard","year":"2011","journal-title":"Radiother Oncol J."},{"key":"pone.0277460.ref032","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2021.01.013","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.","volume":"156","author":"B Lacas","year":"2021","journal-title":"Radiother Oncol J."},{"key":"pone.0277460.ref033","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijsu.2020.04.059","article-title":"Initial surgical versus non-surgical treatments for advanced hypopharyngeal cancer: A meta-analysis with trial sequential analysis","volume":"82","author":"J Cui","year":"2020","journal-title":"Int J Surg"},{"key":"pone.0277460.ref034","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/hed.21081","article-title":"Larynx preservation clinical trial design: key issues and recommendations\u2014a consensus panel summary.","volume":"31","author":"Larynx Preservation Consensus Panel","year":"2009","journal-title":"Head Neck."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0277460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T19:03:51Z","timestamp":1669748631000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0277460"}},"subtitle":[],"editor":[{"given":"Sethu Thakachy","family":"Subha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0277460","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]}}}